Cat. No. | Product name | CAS No. |
DCC3126 |
Lox-activity Sensor-1
Novel LOX-activity sensor for cross-linking with a collagen peptide to chemoselectively target endogenous aldehydes generated by LOX |
|
DCC3127 |
Lp-20 Hydrochloride
Potent ligand of the 5-HT7 receptor |
1386928-34-2 |
DCC3128 |
Lp-261
Potent antimitotic and oral tubulin binding agent, significantly inhibiting growth of a human non-small-cell lung tumor |
915412-67-8 |
DCC3129 |
Lp-922761
Novel potent and selective peripheral AAK1 inhibitor |
1454808-95-7 |
DCC3130 |
Lp-925219
Novel inhibitor of both renal SGLT1 and SGLT2 |
|
DCC3131 |
Lpa1-3 Agonist Cpx
Novel LPA 1-3 agonist, inducing a calcium response in hLPA 1-3 cells within a range of 0.4 to 1.5-log lower potency, as compared to LPA |
|
DCC3132 |
Lpa1-3 Agonist Cpy
Novel LPA 1-3 agonist, inducing a calcium response in hLPA 1-3 cells within a range of 0.4 to 1.5-log lower potency, as compared to LPA |
|
DCC3133 |
Lqfm030
Novel p53 activator through the inhibition of MDM2 |
|
DCC3134 |
Lqmed 330
Novel potent and specific inhibitor of O-linked β-N-acetylglucosamine transferase (OGT) |
|
DCC3135 |
Lrh-1 Agonist 10ca
Novel agonist of liver receptor homolog-1 (LRH-1), reducing the expression of lipogenic genes in mouse liver, and inflammation and disease severity in a mouse model of ulcerative colitis |
|
DCC3136 |
Lrh-1 Agonist-6n
Novel potent agonist of the liver receptor homolog-1 (LRH-1, NR5A2) |
|
DCC3137 |
Lrh-1 Inhibitor-3
The first small molecule antagonist of LRH-1 activity. |
1185410-60-9 |
DCC3138 |
Lsd1 Inhibitor L8
Novel selective and reversible LSD1 inhibitor (IC50 value of 60 nM), exhibiting the antiproliferative activity against HTB5, HTB3, HT1376, and HTB1 cells with IC50 values of 1.87, 0.18, 0.09, and 0.93 μM, respectively |
|
DCC3139 |
Lsd1-in-c26
Novel selective inhibitor of histone lysine specific demethylase 1 (LSD1/KDM1A), displaying FAD-competitive binding to LSD1, concentration-dependently inducing accumulation of H3K4me1/me2 and H3K9me2, increasing expression levels of epithelial cell marker |
|
DCC3140 |
Lsf-oa
Novel prodrug of Lisofylline, maintaining a steady fasting blood glucose level with a significant increase in insulin level |
|
DCC3141 |
Lsf-pa
Novel prodrug of Lisofylline, maintaining a steady fasting blood glucose level with a significant increase in insulin level |
|
DCC3142 |
Lsm-4144
First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation |
|
DCC3143 |
Lsn3160440
Novel positive allosteric modulator (PAM) of the GLP-1R, enhancing insulin secretion in a glucose-, ligand- and GLP-1R-dependent manner |
|
DCC3144 |
Lsn3172176 Precursor
Precursor for 11C-radiolabelling LSN3172176 PET scan |
|
DCC3145 |
Lsn335984 Trihydrochloride
Selective inhibitor of P-glycoproteins (P-gp) |
167356-37-2 |
DCC3146 |
Lspn451
Novel potent xanthine oxidase inhibitor |
474555-58-3 |
DCC3147 |
Lt-106-175
Novel potent inhibitor of FLT3 mutations, also inhibiting CDK2 and CDK6 |
1429515-49-0 |